- Home
- PEPG vs KFS Comparison
PEPG vs KFS Comparison
Compare PEPG & KFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PEPG
- KFS
- Stock Information
- Founded
- PEPG 2018
- KFS 1989
- Country
- PEPG United States
- KFS United States
- Employees
- PEPG N/A
- KFS N/A
- Industry
- PEPG Biotechnology: Pharmaceutical Preparations
- KFS Property-Casualty Insurers
- Sector
- PEPG Health Care
- KFS Finance
- Exchange
- PEPG Nasdaq
- KFS Nasdaq
- Market Cap
- PEPG 250.3M
- KFS 234.2M
- IPO Year
- PEPG 2022
- KFS 1996
- Fundamental
- Price
- PEPG $4.32
- KFS $9.03
- Analyst Decision
- PEPG Buy
- KFS
- Analyst Count
- PEPG 3
- KFS 0
- Target Price
- PEPG $14.67
- KFS N/A
- AVG Volume (30 Days)
- PEPG 133.3K
- KFS 36.8K
- Earning Date
- PEPG 11-07-2024
- KFS 11-06-2024
- Dividend Yield
- PEPG N/A
- KFS N/A
- EPS Growth
- PEPG N/A
- KFS N/A
- EPS
- PEPG N/A
- KFS N/A
- Revenue
- PEPG N/A
- KFS $108,627,000.00
- Revenue This Year
- PEPG N/A
- KFS N/A
- Revenue Next Year
- PEPG N/A
- KFS N/A
- P/E Ratio
- PEPG N/A
- KFS N/A
- Revenue Growth
- PEPG N/A
- KFS 2.02
- 52 Week Low
- PEPG $4.00
- KFS $7.10
- 52 Week High
- PEPG $19.30
- KFS $9.58
- Technical
- Relative Strength Index (RSI)
- PEPG 23.52
- KFS 52.56
- Support Level
- PEPG $4.00
- KFS $8.70
- Resistance Level
- PEPG $4.77
- KFS $9.14
- Average True Range (ATR)
- PEPG 0.56
- KFS 0.32
- MACD
- PEPG -0.05
- KFS -0.05
- Stochastic Oscillator
- PEPG 9.14
- KFS 40.86
About PEPG PepGen Inc.
PepGen Inc is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapeutics to transform the treatment of severe neuromuscular and neurologic diseases. The company has developed its Enhanced Delivery Oligonucleotide platform to improve the uptake and activity of conjugated oligonucleotide therapeutics. Its EDO peptides are engineered to optimize tissue penetration, cellular uptake, and nuclear delivery, and in preclinical studies, it is observed their ability to transport oligonucleotides into a broad range of target tissues, including smooth, skeletal, and cardiac muscle and the central nervous system. Its pipeline products are; PGN-EDO51, PGN-EDODM1, and others including PGN-EDO53 and PGN-EDO45.
About KFS Kingsway Financial Services Inc. (DE)
Kingsway Financial Services Inc through subsidiaries operates in the extended warranty and business services industries in the United States. The company operates through segments namely, Extended Warranty and Kingsway Search Xcelerator. The Extended Warranty segment provides after-market vehicle protection services distributed by credit unions. The firm generates maximum revenue from the Extended Warranty segment in the form of Service fee and commission income.